Signaling pathways in rheumatoid arthritis: implications for targeted therapy

Сигнальные пути при ревматоидном артрите: значение для таргетной терапии
Wei Hu, Qinyan Yang, Yi Zhun Zhu, Qian Ding, Ran Wang, Menglin Zhu, Meng Li, Jianghong Cai, Peter Rose, Jianchun Mao, Peter Rose, Jianchun Mao
2023-02-17

Molecular mechanismsRheumatoid arthritisSignaling pathwaysTargeted therapyTherapeutic inhibitors
Rheumatoid arthritis (RA) is an incurable systemic autoimmune disease. Disease progression leads to joint deformity and associated loss of function, which significantly impacts the quality of life for sufferers and adds to losses in the labor force. In the past few decades, RA has attracted increased attention from researchers, the abnormal signaling pathways in RA are a very important research field in the diagnosis and treatment of RA, which provides important evidence for understanding this complex disease and developing novel RA-linked intervention targets. The current review intends to provide a comprehensive overview of RA, including a general introduction to the disease, historical events, epidemiology, risk factors, and pathological process, highlight the primary research progress of the disease and various signaling pathways and molecular mechanisms, including genetic factors, epigenetic factors, summarize the most recent developments in identifying novel signaling pathways in RA and new inhibitors for treating RA. therapeutic interventions including approved drugs, clinical drugs, pre-clinical drugs, and cutting-edge therapeutic technologies. These developments will hopefully drive progress in new strategically targeted therapies and hope to provide novel ideas for RA treatment options in the future.
1
Abnormal signaling pathways are central to RA diagnosis and treatment research because they help clarify disease mechanisms and identify therapeutic targets.
2
RA interventions span approved, clinical-stage, preclinical, and emerging targeted technologies, supporting development of more strategically targeted treatments.
3
Recent research has identified novel RA-associated signaling pathways and inhibitors with potential therapeutic value.
4
Rheumatoid arthritis is an incurable systemic autoimmune disease whose progression causes joint deformity, functional loss, reduced quality of life, and workforce losses.
5
The review synthesizes genetic, epigenetic, molecular, and signaling-pathway mechanisms contributing to RA pathogenesis.

rheumatoid arthritis

abnormal signaling pathways and molecular mechanisms underlying rheumatoid arthritis, including therapeutic targeting and pathway inhibition

Publication Details
Publication Date
2023-02-17
Journal
Publisher
ISSN
Cited by
605
Access Type
Author Information
Authors
Wei Hu
Qinyan Yang
Yi Zhun Zhu
Qian Ding
Ran Wang
Menglin Zhu
Meng Li
Jianghong Cai
Peter Rose
Jianchun Mao
Peter Rose
Jianchun Mao
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%